They are not for human consumption, veterinary use, diagnostic procedures, cosmetic use, therapeutic applications, or medical treatment
The differences are FDA approval status (weight loss vs diabetes), pricing, and supply availability
When supply gets tight, more questionable listings appear, which makes checking documentation even more important
Since mouse microbiome profiles often highly correlate with body weight and fat composition, this study was designed to test whether the cecal microbiomes of DIO mice treated with NNMTi and LD were comparable to the microbiomes of age-matched lean counterparts and distinct from microbiomes of DIO mice maintained on a high-fat Western diet (WD) or subjected to LD switch alone
Healthcare professionals should approach disclosures of combined peptide use with a non-judgemental but clinically thorough assessment, and provide harm-minimisation advice where appropriate